Stay updated on Duvelisib for COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Duvelisib for COVID-19 Clinical Trial page.

Latest updates to the Duvelisib for COVID-19 Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange Detected- The page shows Revision: v3.5.4 replacing Revision: v3.5.3, indicating an updated document/version label. - This reflects a new revision cycle rather than substantive changes to the page content.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page footer now shows a newer ClinicalTrials.gov UI build/revision number (v3.5.3) instead of the previous one (v3.5.2), indicating an interface/version update rather than a change to the underlying study record.SummaryDifference0.1%

- Check39 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check68 days agoChange DetectedThe site revision label was updated to v3.5.0, replacing the previous v3.4.3 revision.SummaryDifference0.1%

- Check75 days agoChange DetectedAdded the revision label Revision: v3.4.3 to the page. Removed the previous revision label Revision: v3.4.2.SummaryDifference0.1%

- Check104 days agoChange DetectedRevision: v3.4.2 was added and v3.4.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Duvelisib for COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Duvelisib for COVID-19 Clinical Trial page.